Neil Peterson - Aug 1, 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Aug 1, 2022
Transactions value $
-$168,200
Form type
4
Date filed
8/3/2022, 08:17 PM
Previous filing
Apr 29, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock Options Exercise $64.2K +4K $16.05* 4K Aug 1, 2022 Direct
transaction MMSI Common Stock Sale -$232K -4K -100% $58.10 0 Aug 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Options Exercise $0 -4K -100% $0.00* 0 Aug 1, 2022 Common Stock 4K $16.05 Direct F2
holding MMSI Non-qualified stock options (right to buy) 16K Aug 1, 2022 Common Stock 16K $28.20 Direct F3
holding MMSI Non-qualified stock options (right to buy) 15K Aug 1, 2022 Common Stock 15K $44.80 Direct F4
holding MMSI Non-qualified stock options (right to buy) 20K Aug 1, 2022 Common Stock 20K $54.40 Direct F5
holding MMSI Non-qualified stock options (right to buy) 25K Aug 1, 2022 Common Stock 25K $68.33 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.64 to $60.99, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 Became exercisable in equal annual installments of 20% commencing 1/28/2017.
F3 Became exercisable in equal annual installments of 20% commencing 4/14/2018.
F4 Became exercisable in equal annual installments of 20% commencing 3/2/2019.
F5 Became exercisable in equal annual installments of 20% commencing 4/25/2020.
F6 Became exercisable in equal annual installments of 25% commencing 8/19/2022.